AKTX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 11:09):

Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases...

Stats
Today's Volume	1 968.00
Average Volume	15 580.00
Market Cap	9.59M
EPS	$2.00 ( 2023-10-03 )
Next earnings date	( $0 ) 2024-05-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.710
ATR14	$0.0400 (2.76%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-26	Jacques Rachelle Suzanne	Buy	479 569 892	Ordinary Shares, par value $0.0001 per share
2024-01-01	Jacques Rachelle Suzanne	Sell	0	Ordinary Shares, par value $0.0001 per share
2024-01-01	Jacques Rachelle Suzanne	Sell	29 762 300	Stock Option (Right to Buy)
2023-06-01	Jacques Rachelle Suzanne	Sell	152 690 700	Stock Option (Right to Buy)
2024-07-17	Dicicco Wendy F	Sell	5 000 000	Stock Option (Right to Buy)

INSIDER POWER
48.63
Last 82 transactions
Buy: 548 511 705 \| Sell: 428 349 677

Volume Correlation

Long: 0.20 (neutral)

Short: 0.34 (neutral)

Signal:(41.338) Neutral

Akari Therapeutics PLC Correlation

10 Most Positive Correlations
HCDIP	0.976
NAKD	0.968
SNGX	0.964
DIBS	0.963
GROM	0.963
AVIR	0.962
JAGX	0.962
CSSE	0.962
PRTS	0.961
PSTX	0.961

10 Most Negative Correlations
AEAC	-0.974
SVFA	-0.973
SWAV	-0.971
KAII	-0.971
AGZD	-0.97
LGACU	-0.967
SVFAU	-0.967
SCOB	-0.966
ABGI	-0.966
MCAA	-0.966

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Akari Therapeutics PLC Correlation - Currency/Commodity

0.69
( moderate )

0.67
( moderate )

0.00
( neutral )

0.68
( moderate )

-0.40
( neutral )

-0.68
( moderate negative )

Akari Therapeutics PLC Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-4 000.00 (0.00 %)
EPS:	$-2.04

FY	2023
Revenue:	$0
Gross Profit:	$-4 000.00 (0.00 %)
EPS:	$-2.04

FY	2022
Revenue:	$0
Gross Profit:	$-3 708.00 (0.00 %)
EPS:	$-2.23

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-0.406

Financial Reports:

No articles found.

Akari Therapeutics PLC

Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-Barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous pemphigoid. Akari Therapeutics, Plc is based in London, the United Kingdom.

Realtime updates for Akari Therapeutics PLC [AKTX]

Upcoming Earnings Alert